A Coiled-Coil Mimetic Intercepts BCR-ABL1 Dimerization in Native and Kinase-Mutant Chronic Myeloid Leukemia

Targeted therapy of chronic myeloid leukemia is currently based on small-molecule inhibitors that directly bind the tyrosine kinase domain of BCR-ABL1. This strategy has generally been successful, but is subject to drug resistance due to point mutations in the kinase domain. Kinase activity requires...

Descripción completa

Detalles Bibliográficos
Autores principales: Woessner, David W., Eiring, Anna M., Bruno, Benjamin J., Zabriskie, Matthew S., Reynolds, Kimberly R., Miller, Geoffrey D., O’Hare, Thomas, Deininger, Michael W., Lim, Carol S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621806/
https://www.ncbi.nlm.nih.gov/pubmed/25721898
http://dx.doi.org/10.1038/leu.2015.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621806/
https://www.ncbi.nlm.nih.gov/pubmed/25721898
http://dx.doi.org/10.1038/leu.2015.53

Ejemplares similares